Tomasello Shawn
SEC CIK 1617239 · EDGAR
BoughtSold
Most active insiders at CABA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Nichtberger Steven | Pres, CEO, Dir | $100.8K | — |
| 2 | Gavel Steve | Chief Commercial Off | $50.3K | — |
| 3 | Tomasello Shawn | Dir | $50.2K | — |
| 4 | Simon Mark | Dir | $25.2K | — |
| 5 | Binder Gwendolyn | Pres, Science, Tech | $24.8K | — |
| 6 | Chang David J. | Chief Medical Off | $19.9K | — |
| 7 | Gerard Michael | GC | $15.0K | — |
| 8 | Bollard Catherine | Dir | $9,999 | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-01-21 | 2026-01-21 | CABA | Cabaletta Bio, Inc. | Tomasello Shawn | Dir | P - Purchase | $2.21 | +22.7K | 22.7K | New | +$50.2K |
| 2024-06-07 | 2024-06-06 | KLRS | Kalaris Therapeutics, Inc. | Tomasello Shawn | Dir | A - Grant | $0.00 | +35.0K | 70.0K | +100% | $0 | |
| 2023-05-12 | 2023-05-11 | KLRS | Kalaris Therapeutics, Inc. | Tomasello Shawn | Dir | A - Grant | $0.00 | +35.0K | 35.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations